Anti-TNF Treatments

In people with Crohn's disease, the immune system produces too much of a protein called TNF-alpha (tumor necrosis factor-alpha). TNF-alpha triggers inflammation, which can lead to inconvenient, and often painful, symptoms and damage to your gastrointestinal (GI) tract.

Some medications used to treat the symptoms of moderate to severe Crohn's disease are called biologics. Anti-TNFs are a type of biologic that target TNF-alpha and block it from causing inflammation in your GI tract.

CIMZIA—the only PEGylated anti-TNF

CIMZIA is used to lessen the signs and symptoms of moderately to severely active Crohn's disease in adults who have not been helped enough by usual treatments.

CIMZIA is the only PEGylated anti-TNF. CIMZIA has an innovative design, allowing it to be injected just once every 4 weeks after initial dosing. Initial dosing consists of 1 dose provided as 2 separate injections at Week 0, Week 2, and Week 4.

Learn more about what makes CIMZIA different.